Ascentage Pharma Group International (AAPG) Goodwill & Intangibles (2022 - 2025)
Ascentage Pharma Group International posted quarterly Goodwill & Intangibles of $12.8 million for Q4 2025, down 8.84% year-on-year from $14.0 million in Q4 2024, and down 3.41% on a QoQ basis from $13.2 million in Q2 2025.
Ascentage Pharma Group International (AAPG) has 4 years of Goodwill & Intangibles data on file, last reported at $12.8 million in Q4 2025.
- For the quarter ending Q4 2025, Goodwill & Intangibles fell 8.84% year-over-year to $12.8 million; the trailing twelve-month figure through Dec 2025 stood at $12.8 million (down 8.84% YoY), and the FY2025 full-year result was $12.6 million, down 10.03% from the prior year.
- Goodwill & Intangibles for Q4 2025 stood at $12.8 million, down from $13.2 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $14.0 million in Q4 2024 and bottomed at $4.0 million in Q4 2022.
- The 4-year median for Goodwill & Intangibles is $12.8 million (2025), against an average of $10.8 million.
- The widest annual swing landed in 2023, when Goodwill & Intangibles surged 151.16%; it then fell 8.84% in 2025.
- A 4-year view of Goodwill & Intangibles shows it stood at $4.0 million in 2022, then soared by 151.16% to $10.1 million in 2023, then jumped by 38.67% to $14.0 million in 2024, then declined by 8.84% to $12.8 million in 2025.
- The last three Goodwill & Intangibles figures came in at $12.8 million (Q4 2025), $13.2 million (Q2 2025), and $14.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Ascentage Pharma Group International | 1.11 Bn | 937.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.78 Mn |
| Jun 30, 2025 | 13.23 Mn |
| Dec 31, 2024 | 14.02 Mn |
| Dec 31, 2023 | 10.11 Mn |
| Dec 31, 2022 | 4.02 Mn |